RECOGNITION OF DNA BY THE E2 PROTEIN FROM PAPILLOMAVIRUS
乳头瘤病毒 E2 蛋白对 DNA 的识别
基本信息
- 批准号:2390384
- 负责人:
- 金额:$ 9.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-04-01 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this investigation is to understand how the E2 protein from
papillomavirus recognizes DNA. Three-dimensional structures will be
determined using nuclear magnetic resonance (NMR) spectroscopy for the
DNA-binding domain of bovine papillomavirus (BPV1) E2 protein, the DNA to
which E2 protein binds, and mutants of the protein. The approach will be
to: l, Purify recombinant forms of the protein; 2, Optimize conditions for
NMR spectroscopy; 3, Obtain NMR data for the DNA-binding domain; 4, Study
site-specific mutants of E2; 5, Obtain NMR data for the binding-site DNA;
6, Determine structures from the NMR data; 7, Measure dynamics in the
protein; and 8, Perform molecular modeling studies on the structures
determined. The DNA-binding domain encompasses the most C-terminal 101
residues (310-410) of bovine papillomavirus E2 protein. This includes a 16
amino acid residue segment that has not been studied before structurally
and which clearly appears to be important for E2 protein function. A
comparison of structures for the previously published protein-DNA complex
to that of the unbound protein and unbound DNA will reveal the
conformational changes that the protein and DNA must undergo in order to
recognize each other. Furthermore, dynamics within the protein will be
studied by amide proton exchange and relaxation time measurements to
understand the role of flexibility in the E2 protein-DNA recognition
process. An important feature of this application is the study of site-
specific mutants of E2 protein. Although many of these mutants have been
characterized as to their DNA-binding and transactivating ability little
is known about the structural consequences of introducing the amino acid
change. Alteration of structure caused by replacement of the cysteine in
the DNA recognition helix will be examined in particular since the DNA-
binding affinity of E2 may be regulated by modification of cysteinyl
sulfur through a novel reduction/oxidation mechanism. The papillomaviruses
are a small family of DNA viruses that cause epithelial tumors in a
variety of vertebrate hosts. The genetics and biochemistry of bovine
papillomavirus (BPV1) have been most extensively characterized. The human
(HPV) and bovine viruses have many properties in common, including
homologous DNA-binding domains of E2 protein. E2 plays essential roles in
both viral DNA replication and viral gene expression and therefore
regulates viral growth and transformation of the host cell. In humans the
vast majority of cervical carcinomas contain HPV viral DNA. A better
understanding of the way in which E2 regulates viral activity is an
important first step in the development of novel methods to correct
aberrant processes in cellular control such as those associated with
cancer caused by the human virus.
这项研究的目的是了解如何从
乳头瘤病毒识别DNA。三维结构将是
使用核磁共振(NMR)光谱测定
牛乳头瘤病毒(BPV1)E2蛋白的DNA结合结构域,DNA至
E2蛋白结合了蛋白质的突变体。方法将是
到:l,纯化蛋白质的重组形式; 2,优化条件
NMR光谱; 3,获得DNA结合域的NMR数据; 4,研究
E2的位点特异性突变体; 5,获得结合位点DNA的NMR数据;
6,从NMR数据确定结构; 7,测量动力学
蛋白质; 8,对结构进行分子建模研究
决定。 DNA结合域涵盖了最多的C末端101
牛乳头瘤病毒E2蛋白的残基(310-410)。这包括16
氨基酸残基段,在结构上尚未研究
这显然对于E2蛋白功能很重要。一个
比较先前发表的蛋白-DNA复合物的结构
对于未结合的蛋白质和未结合的DNA的DNA将揭示
蛋白质和DNA必须经历的构象变化才能
互相认识。此外,蛋白质内的动力学将是
由酰胺质子交换和放松时间测量到
了解灵活性在E2蛋白DNA识别中的作用
过程。该应用的一个重要特征是研究站点 -
E2蛋白的特异性突变体。尽管这些突变体中有许多已经
其DNA结合和反式激活能力的特征很少
已经知道引入氨基酸的结构后果
改变。通过替代半胱氨酸引起的结构的改变
DNA识别螺旋将特别检查,因为DNA-
E2的结合亲和力可以通过Cysteinyl的修饰来调节
通过新颖的还原/氧化机制硫。乳头瘤病毒
是在A中引起上皮肿瘤的一小部分DNA病毒
各种脊椎动物宿主。牛的遗传学和生物化学
乳头瘤病毒(BPV1)的表征最广泛。人类
(HPV)和牛病毒具有许多共同特性,包括
E2蛋白的同源DNA结合结构域。 E2在
病毒DNA复制和病毒基因表达,因此
调节宿主细胞的病毒生长和转化。在人类中
绝大多数宫颈癌含有HPV病毒DNA。更好
了解E2调节病毒活性的方式是一种
开发新方法以纠正的重要第一步
细胞控制中的异常过程,例如
人类病毒引起的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
JAMES D BALEJA的其他基金
Diagnosis of Heart Failure Status using Epidermal Metabolomics
使用表皮代谢组学诊断心力衰竭状态
- 批准号:97941429794142
- 财政年份:2018
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in B cell Development
B 细胞发育中的分子相互作用
- 批准号:72299887229988
- 财政年份:2006
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in B cell Development
B 细胞发育中的分子相互作用
- 批准号:70361237036123
- 财政年份:2006
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in Signaling and Vesicle Sorting
信号传导和囊泡分选中的分子相互作用
- 批准号:70128317012831
- 财政年份:2004
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in Signaling and Vesicle Sorting
信号传导和囊泡分选中的分子相互作用
- 批准号:71754617175461
- 财政年份:2004
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in Signaling and Vesicle Sorting
信号传导和囊泡分选中的分子相互作用
- 批准号:68450996845099
- 财政年份:2004
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Molecular Interactions in Signaling and Vesicle Sorting
信号传导和囊泡分选中的分子相互作用
- 批准号:67317916731791
- 财政年份:2004
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
STRUCTURE DETERMINATION OF PROTEINS ASSOCIATED W/ CANCER
与癌症相关的蛋白质的结构测定
- 批准号:63551586355158
- 财政年份:2000
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
STRUCTURE DETERMINATION OF PROTEINS ASSOCIATED W/ CANCER
与癌症相关的蛋白质的结构测定
- 批准号:61186456118645
- 财政年份:1999
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
DESIGN OF UMAN PAPILLOMAVIRUS INHIBITORS
乌曼乳头状病毒抑制剂的设计
- 批准号:63734766373476
- 财政年份:1995
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
相似国自然基金
RNA结合蛋白QKI调控DNA损伤修复的功能及机制研究
- 批准号:82303054
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
染色质解旋酶DNA结合蛋白2调控禽白血病病毒复制的分子机制研究
- 批准号:32302872
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA甲基转移酶DNMT3A与RNA结合蛋白RBM47通过调控GSTA1表达参与胶质瘤进展作用机制探讨
- 批准号:82360475
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
单链DNA结合蛋白RPA32的棕榈酰化修饰调控复制胁迫应答的机制研究
- 批准号:32371358
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
酸性核质DNA结合蛋白1(AND1)调控p53稳定性促进非小细胞肺癌放射抵抗的作用机制研究
- 批准号:82303681
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck
多重溶液内蛋白质芯片 (MISPA) 用于对病原体引起的头颈部进行高通量、定量、早期分析
- 批准号:1071392810713928
- 财政年份:2023
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Interplay between the cellular DNA damage response and the HPV life cycle
细胞 DNA 损伤反应与 HPV 生命周期之间的相互作用
- 批准号:1073439410734394
- 财政年份:2023
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Determining the mechanism for YAP1 activation by HPV E7 in oropharyngeal carcinoma
确定口咽癌中 HPV E7 激活 YAP1 的机制
- 批准号:1060611010606110
- 财政年份:2023
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
Synthetic Transcriptional Activators for Cancer Immunotherapy
用于癌症免疫治疗的合成转录激活剂
- 批准号:1085010910850109
- 财政年份:2023
- 资助金额:$ 9.9万$ 9.9万
- 项目类别:
An investigation of how filopodia can be exploited by peptide carriers for enhanced uptake of RNAi cargo for the treatment of HPV+ oral cancers.
研究肽载体如何利用丝状伪足来增强 RNAi 货物的摄取,从而治疗 HPV 口腔癌。
- 批准号:1067816610678166
- 财政年份:2023
- 资助金额:$ 9.9万$ 9.9万
- 项目类别: